良好的1年和5年移植器官生存率支持采用SPK治疗1型糖尿病相关的终末期肾病。
Excellent 1 - and 5-year organ survival rates favor the use of SPK in type 1 diabetics associated with end-stage renal disease.
目的探讨回声跟踪（ET）技术对终末期肾病（ESRD）患者颈动脉弹性的检测及其意义。
Objective To detect the carotid elasticity quantitatively in end-stage renal disease(ESRD) patients using echo-tracking(ET)technique.
目的：评价低钙透析液和含钙的磷结合剂治疗对终末期肾病腹膜透析患者钙磷代谢紊乱和冠状动脉钙化进展的影响。
Objective: to evaluate the effect of low-calcium peritoneal dialysate and phosphate binder on calcium and phosphate abnormality and coronary artery calcification of end-stage renal disease patients.
目的建立和优化终末期肾病患者血清蛋白质组研究的双向电泳及相关技术，并与正常血清蛋白图谱比较。
Objective To establish and optimize the two-dimensional gel electrophoresis technical platform for the blood serum proteome research in patients with end stage renal disease(ESRD).
死亡者及发生终末期肾病者的FGF23水平，显示高于未发生这类情况者。
FGF23 levels were significantly higher in the patients who later died or reached end-stage renal disease than in those who didn't.
目的：糖尿病肾病是糖尿病常见微血管并发症之一，也是导致终末期肾功衰竭的主要原因之一。
Objective: Diabetic nephropathy is a common complication of diabetic microvascular complications and a leading cause of end stage renal failure.
目的探讨单次血液透析对终末期肾病(ESRD)患者动脉功能的急性效应及其影响因素。
Objective to investigate the acute effect of arterial function and explore the influence factor on hemodialysis patients with end-stage renal disease (ESRD).
糖尿病肾病是发达国家终末期肾病的主要病因。
Background Diabetic nephropathy is the leading cause of end-stage renal disease in developed countries.
糖尿病肾病终末期患者有广泛的血管病变，首选腹膜透析治疗较安全有效。
For patients with severe blood vessel complications, peritoneal dialysis is often the first choice for its safety and effectiveness.
目的：糖尿病肾病是糖尿病常见的微血管并发症，是糖尿病的主要死因之一，同时也是终末期肾衰竭的首要原因。
Objective: Diabetic Nephropathy, which is the hackneyed capillary vessel syndrome, is one of the important reasons for death of diabetes.
目的：肾间质纤维化(RIF)是各种不同病因的慢性肾脏病(CKD)随着病程进展进入终末期肾病(ESRD)的一个进行性、不可逆的共同途径。
OBJECTIVE: the renal interstitial fibrosis (RIF) is almost the common pathway by which all the various chronic kidney diseases (CKD) progress to end stage renal disease (ESRD).
在经过充分校正的分析中，GF R估算值的下降是终末期肾病的最强的预测因子，而GF R估算值可修正FGF - 23与终末期肾病风险之间的关系。
Reduced estimated GFR was the strongest predictor of end-stage renal disease in fully adjusted analysis, and estimated GFR modified the relationship between FGF-23 and risk of end-stage renal disease.
目的探讨终末期肾病（ESRD）首诊患者的焦虑-抑郁水平及其影响因素。
Objective To investigate the anxiety-depression level in the patients with firstly-diagnosed end-stage renal disease (ESRD) and its influencing factor.
目的评估终末期肾病患者家庭照料者的生活质量。
Objective To evaluate the QOL of family caregivers of patients with end-stage renal disease.
目的：探讨心脏超声检查终末期肾病(ESRD)患者心脏瓣膜钙化的临床价值。
Objective: To detect the calcification of cardiac valve and its degree on echocardiography in ESRD patients, and evaluate its utility in clinic.
同样，肾脏并发症通常是由蛋白尿的进展、终末期肾病、以及死亡来预示。
Likewise, in renal complications, usually heralded by the development of protein urea and end-stage renal disease, and mortality also.
研究人员发现，那些死亡或进展到终末期肾病患者的FGF-23中位数水平显著高于那些无事件发生患者的FGF-23中位数水平。
The researchers found that median FGF-23 levels were significantly higher in those who died or reached end-stage renal disease than in those who remained event-free.
在中位数(中点)为3.5年的随访中，有266位参与者死亡，有410人进展到了终末期肾病。
During a median (midpoint) follow-up of 3.5 years, 266 participants died and 410 reached end-stage renal disease.
腹膜透析治疗对终末期糖尿病肾病患者是安全有效的，并可作为该病肾脏替代治疗的首选方法。
Peritoneal dialysis is confirmed safe and effective, and should be the optimal method as renal replacement therapy for end-stage diabetic nephropathy patients.
研究背景和目的糖尿病肾病(DN)是导致终末期肾病的主导因素，也是糖尿病患者致死、致残的主要原因。
Background and ObjectiveDiabetic nephropathy (DN) is the leading cause of end-stage renal disease and a major contributing cause of morbidity and mortality in patients with diabetes.
糖尿病肾病是糖尿病的主要并发症之一，也是终末期肾衰的元凶，其发病机制至今尚未阐明。
Diabetic nephropathy (DN) is one of the main complications of diabetes, it has become the leading cause of end stage renal failure, the pathogenesis of DN has not been completely clarified so far.
摘要：腹膜透析作为一种有效的肾脏替代治疗，在终末期肾病中运用日渐广泛，甚至成为肾脏替代治疗的首选方案。
Abstract: as an effective renal replacement therapy, peritoneal dialysis is widely used in patients with end-stage kidney disease.
糖尿病肾病（DN）是糖尿病（DM）主要的慢性并发症之一，是导致慢性肾功能不全的常见原因，在终末期肾病病人中约三分之一是由DN引起的。
Diabetic nephropathy (DN) is one of the main chronic complicants of diabetic mellitus (DM) as well as the common reason resulting in chronic renal failure, one third of which is caused by DN.
目的了解终末期肾病患者早期死亡的原因和危险因素。
Objective to analyze the etiology and the related factors of end stage renal disease (ESRD) with hemodialysis.
目的了解终末期肾病患者早期死亡的原因和危险因素。
Objective to analyze the etiology and the related factors of end stage renal disease (ESRD) with hemodialysis.
应用推荐